WARRANTS AND OPTIONS - Options outstanding, shares issued to employees under stock option plan (Details)	9 Months Ended
	Sep. 30, 2016 $ / shares shares
Employee option, Exercise Price A
Options Outstanding
Exercise prices	$ 0.80
Number outstanding \| shares	85,000
Weighted average remaining contractual life	4 years 5 months 12 days
Weighted average exercise price	$ 0.80
Options Exercisable
Number exercisable \| shares	85,000
Weighted average exercise price	$ 0.80
Employee option, Exercise Price B
Options Outstanding
Exercise prices	$ 1.00
Number outstanding \| shares	185,000
Weighted average remaining contractual life	3 years 9 months 7 days
Weighted average exercise price	$ 1.00
Options Exercisable
Number exercisable \| shares	157,917
Weighted average exercise price	$ 1.00
Employee option, Exercise Price C
Options Outstanding
Exercise prices	$ 1.11
Number outstanding \| shares	100,000
Weighted average remaining contractual life	4 years 3 months
Weighted average exercise price	$ 1.11
Options Exercisable
Number exercisable \| shares	100,000
Weighted average exercise price	$ 1.11
Employee option, Exercise Price D
Options Outstanding
Exercise prices	$ 1.25
Number outstanding \| shares	600,000
Weighted average remaining contractual life	4 years 11 months 1 day
Weighted average exercise price	$ 1.25
Options Exercisable
Number exercisable \| shares	262,500
Weighted average exercise price	$ 1.25
Employee option, Exercise Price E
Options Outstanding
Exercise prices	$ 2.25
Number outstanding \| shares	162,696
Weighted average remaining contractual life	1 year 7 months 24 days
Weighted average exercise price	$ 2.25
Options Exercisable
Number exercisable \| shares	162,696
Weighted average exercise price	$ 2.25
Employee option, Exercise Price Weighted Average Total
Options Outstanding
Number outstanding \| shares	1,132,696
Weighted average remaining contractual life	4 years 2 months 1 day
Weighted average exercise price	$ 1.31
Options Exercisable
Number exercisable \| shares	768,113
Weighted average exercise price	$ 1.34

IRIS BIOTECHNOLOGIES INC 10-Q